You searched for "regeneration"

2297 results found

Mainline Instruments Announces NHS Approval for iCare DRSplus Fundus Imaging System

Mainline Instruments is excited to share that the iCare DRSPlus Confocal Fundus Imaging System has received official approval from the NHS for use in the Diabetic Eye Screening (DES) Programme. This recognition follows a rigorous evaluation process, confirming that the...

MacuMira and Keeler announce strategic partnership to expand dry AMD therapy

Keeler, a global leader in ophthalmic innovation with more than a century of heritage, and MacuMira Medical Devices Inc, a pioneering Canadian company, has announced a strategic partnership. Under the agreement, Keeler will manufacture the MacuMira device and lead its...

Understanding amniotic membrane grafts

Safa Elhassan gives a brief review of amniotic membrane grafts and their application in theatre and clinic-based settings. Amniotic membrane (AM) transplant has been an established adjuvant treatment for many corneal, conjunctival and scleral disorders in ophthalmic clinical practice with...

Winner announced for the Silmo IOA International Optician of the Year Award

The International Opticians Association (IOA) has announced the winner of the Silmo IOA International Optician of the Year Award. This innovative award recognises the importance of the optician in the optical business and their role in the choice of optimum products for their clientele.

Congenital aniridia with or without retinal detachment

The authors present the clinical and molecular genetic evaluations performed on a large Iranian pedigree with 26 aniridia affected patients in four generations and some with retinal detachment. Members of the family affected with aniridia were invited to participate after...

Amendments to NHS performers list regulations

The Department of Health and Social Care (DHSC) recently conducted a very short consultation without notice regarding changes to the NHS (England, Performers Lists) Regulation 2013.

Telemedicine strategies in ophthalmology: harnessing established and emerging technologies for lasting solutions

The author considers recent progress and shares insights from leading practitioners in telemedicine applications and digital technology strategies. Amidst COVID-19 and combined mitigation and suppression measures, hospitals and clinics have responded rapidly to strengthen telemedicine strategies and virtual healthcare services...

The role of inflammation in the pathophysiology of DMO

Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...

Stem cell transplantation and pterygium surgery

Pterygium is a benign, fibrovascular overgrowth of bulbar conjunctiva extending onto the cornea and has been associated with ultraviolet (UV) light exposure. The prevalence of pterygium worldwide varies between geographical zones but has been reported to range between three and...

Topography-guided photorefractive keratectomy in the treatment of corneal scarring

This study reports the outcome of topography-guided photorefractive keratectomy (TG-PRK) in the treatment of patients with corneal scarring. A retrospective case series including six eyes of six patients with corneal scarring and irregular astigmatism who underwent topography guided PRK. The...

Conference Report: UKISOP marks World Sight Day with multidisciplinary webinar: Supporting adults and children with sight loss

To commemorate World Sight Day 2025, the UK & Ireland Society of Ophthalmic Practitioners (UKISOP) hosted a dynamic online learning session titled 'Supporting Adults and Children with Sight Loss' on October 9 2025. The event brought together over sixty professionals...

Exciting opportunities for ophthalmic surgeons with the UK and Europe’s leading provider of cataract surgery, lens replacement surgery and laser eye surgery.

We have opportunities across the UK and Ireland for ophthalmic surgeons to treat private pay, PMI and NHS funded patients.